All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Seven years on, CRT may be the way forward for RMBS

The outlook for private label RMBS in the US is decidedly bleak, even seven years after the crisis, and investors may need to get used to the idea that agency credit risk transfer (CRT) deals may the closest the market comes to a return to the glory days.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree